« Alle Studien

BENEFIT-EXT Studie

Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial-EXTended criteria donors

Literaturstellen

Am.J.Transplant. 2010,10,547; 2012,12,630; 2015,15Suppl.3, abstract; 2016,16,3192
Transplantation 2010,90,1528